Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Simulations Plus stock

Learn how to easily invest in Simulations Plus stock.

Simulations Plus Inc is a health information services business based in the US. Simulations Plus shares (SLP) are listed on the NASDAQ and all prices are listed in US Dollars. Simulations Plus employs 135 staff and has a trailing 12-month revenue of around $52 million.

How to buy shares in Simulations Plus

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SLP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Simulations Plus stock price (NASDAQ: SLP)

Use our graph to track the performance of SLP stocks over time.

Simulations Plus shares at a glance

Information last updated 2022-09-26.
Latest market close$48.54
52-week range$35.10 - $67.59
50-day moving average $60.27
200-day moving average $49.49
Wall St. target price$65.25
PE ratio 84.9474
Dividend yield $0.24 (0.5%)
Earnings per share (TTM) $0.57

Buy Simulations Plus shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Simulations Plus stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Simulations Plus price performance over time

Historical closes compared with the close of $48.54 from 2022-09-27

1 week (2022-09-22) -1.44%
1 month (2022-08-25) N/A
3 months (2022-06-29) -0.19%
6 months (2022-03-29) 0.08%
1 year (2021-09-29) 23.07%
2 years (2020-09-29) -35.11%
3 years (2019-09-27) 42.68%
5 years (2017-09-29) 213.16%

Is Simulations Plus stock undervalued or overvalued?

Valuing Simulations Plus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Simulations Plus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Simulations Plus's P/E ratio

Simulations Plus's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 85x. In other words, Simulations Plus shares trade at around 85x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Simulations Plus's PEG ratio

Simulations Plus's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 9.7712. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Simulations Plus's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Simulations Plus's EBITDA

Simulations Plus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $16.7 million.

The EBITDA is a measure of a Simulations Plus's overall financial performance and is widely used to measure a its profitability.

Simulations Plus financials

Revenue TTM $52 million
Operating margin TTM 27.67%
Gross profit TTM $35.9 million
Return on assets TTM 4.92%
Return on equity TTM 6.9%
Profit margin 22.74%
Book value $8.78
Market capitalisation $979.8 million

TTM: trailing 12 months

Simulations Plus share dividends


Dividend payout ratio: 42.11% of net profits

Recently Simulations Plus has paid out, on average, around 42.11% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.5% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Simulations Plus shareholders could enjoy a 0.5% return on their shares, in the form of dividend payments. In Simulations Plus's case, that would currently equate to about $0.24 per share.

While Simulations Plus's payout ratio might seem fairly standard, it's worth remembering that Simulations Plus may be investing much of the rest of its net profits in future growth.

Simulations Plus's most recent dividend payout was on 31 July 2022. The latest dividend was paid out to all shareholders who bought their shares by 21 July 2022 (the "ex-dividend date").

Have Simulations Plus's shares ever split?

Simulations Plus's shares were split on a 2:1 basis on 1 October 2007. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Simulations Plus shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Simulations Plus shares which in turn could have impacted Simulations Plus's share price.

Simulations Plus share price volatility

Over the last 12 months, Simulations Plus's shares have ranged in value from as little as $35.1015 up to $67.59. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Simulations Plus's is 0.4415. This would suggest that Simulations Plus's shares are less volatile than average (for this exchange).

Simulations Plus overview

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions.

Frequently asked questions

What percentage of Simulations Plus is owned by insiders or institutions?
Currently 20.923% of Simulations Plus shares are held by insiders and 75.017% by institutions.
How many people work for Simulations Plus?
Latest data suggests 135 work at Simulations Plus.
When does the fiscal year end for Simulations Plus?
Simulations Plus's fiscal year ends in August.
Where is Simulations Plus based?
Simulations Plus's address is: 42505 Tenth Street West, Lancaster, CA, United States, 93534-7059
What is Simulations Plus's ISIN number?
Simulations Plus's international securities identification number is: US8292141053
What is Simulations Plus's CUSIP number?
Simulations Plus's Committee on Uniform Securities Identification Procedures number is: 713831105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site